What Lysozyme Hydrochloride Treats: Main Uses and Benefits

Lysozyme Hydrochloride is commonly used across domains where additional symptomatic support is needed for oral and pharyngeal inflammation. The use of this agent is considered relevant in clinical settings that involve acute or unstable symptom patterns, such as acute inflammation.

The preparation is commonly used across conditions presenting with acute episodes of the throat and mouth, including pharyngitis, tonsillopharyngitis, stomatitis, gingivitis, and minor mouth ulcers (aphthae). It helps address symptom clusters associated with these episodes, such as sore throat, irritation, and painful or difficult swallowing.

This localized support contributes to easing the overall symptom load and assists with maintaining functional stability during periods of heightened discomfort. It is also applied in clinical contexts involving support for tissue recovery, such as after minor oral procedures, or for easing non-infectious throat irritation. It supports the patient during difficult episodes of heightened discomfort.

---

Quick Fact: Support for Localized Pain and Swelling

This supportive therapy may be part of symptomatic management for conditions where functional stability may be affected, providing supportive relief when symptoms interfere with routine activities.

The eligibility for using Lysozyme Hydrochloride is strictly determined by its official regulatory labeling, focusing on the potential for allergic reactions and caution for vulnerable populations.

Absolute Contraindications

Lysozyme Hydrochloride is absolutely contraindicated and must not be used by individuals with a known allergy to:

• Lysozyme itself or any other ingredient in the product.
• Eggs or hen egg white protein, as the active substance is derived from egg white and poses a risk of severe hypersensitivity reactions, including anaphylaxis.

Restricted and Conditional Use

Use in the following populations is conditional, often requiring explicit consultation with a physician or pharmacist:

Population Group	Eligibility Status
Young Children	Restricted/Not Recommended (Specific age thresholds, e.g., le 6 years, are often prohibited or require prescription).
Pregnant Women	Conditional Use (Only if clearly needed and strictly under medical advice).
Breastfeeding Women	Conditional Use (Only if clearly needed and strictly under medical advice).

Adults and the Elderly (Geriatric patients) are the primary populations for whom the medicine is generally allowed under its standard labeled conditions, though caution is still advised for the elderly.

The official interaction profile for Lysozyme Hydrochloride is based on the interaction properties of its two active components: the enzyme Lysozyme and the co-formulated Pyridoxine (Vitamin B6).

Pharmacodynamic and Co-Administration Constraints

Classification	Interacting Substance / Category
Pharmacodynamic Interaction	Levodopa (L-Dopa)
Timing Restriction	Other Antiseptics

The most significant systemic interaction is documented to involve Levodopa. The Pyridoxine component may cause an increase in the peripheral metabolism of levodopa, which is officially associated with a reduction in the therapeutic efficacy of Levodopa. This exposure-modifying effect is generally relevant only when Levodopa is administered without a concomitant dopa decarboxylase inhibitor, as stated in regulatory prescribing information.

In terms of local use, there is an official co-administration restriction: the product should not be used simultaneously with other medicines containing an antiseptic on the oral and pharyngeal mucosa. This restriction is based on the Lysozyme component's classification as a local antiseptic agent.

Absence of Systemic Metabolic Interactions

The regulatory profile does not document any systemic interactions involving major drug-metabolizing enzymes (such as the Cytochrome P450 system) or drug transporter proteins. Furthermore, no specific interactions with food, alcohol, or herbal products are formally documented in the available regulatory labeling.

Enzymatic Hydrolysis of the Bacterial Cell Wall

Lysozyme Hydrochloride exerts its primary effect as an enzyme by initiating the cleavage of the peptidoglycan layer within susceptible bacterial cell walls. Specifically, the enzyme catalyzes the hydrolysis of the beta-(1,4) glycosidic bonds between N-acetylmuramic acid and N-acetylglucosamine residues. This targeted enzymatic cascade compromises the structural rigidity of the cell wall, allowing the high internal osmotic pressure to exceed the wall's integrity. The consequent influx of water leads rapidly to cell lysis (rupture), which is the primary mechanistic consequence of this beta-(1,4) glycosidase activity.

---

Modulatory Activity and Membrane Interactions

Beyond its lytic role, the molecule also engages in secondary, non-enzymatic activities driven by its cationic charge. These cationic interactions facilitate the disruption of the bacterial membrane and alter its permeability. Furthermore, Lysozyme is known to influence pathways that modulate local physiological responses. These mechanisms influence intracellular signaling sequences involving the release of specific endogenous mediators.

Lysozyme Hydrochloride is administered through two primary routes, each corresponding to a specific dosage form: Oral Mucosal for lozenge preparations intended for local action, and Oral for tablets or syrups used for systemic absorption. The instructions for use are dependent on the formulation.

---

Administration and Dosing Regimens

Parameter	Official Guideline
Routes of Administration	Oral Mucosal (Lozenges) and Oral (Tablets, Syrup).
Adult Dosing (Tablet)	The standard systemic regimen is 90 mg per dose, taken two to three times daily.
Lozenge Administration	For local effect, lozenges are typically administered in divided doses throughout the day, often with an interval of one to two hours between uses.

---

Procedural and Age-Group Instructions

The method of use is procedural based on the form. Tablets must be swallowed whole with water and should not be crushed or chewed to maintain the integrity of the dose. Conversely, lozenges must be placed in the mouth and allowed to dissolve slowly to ensure optimal localized delivery.

For pediatric use, specific syrup formulations are utilized, with the volume (mL) adjusted according to the child’s age and typically administered three times daily. Treatment for all forms is defined as a short-term course, generally not exceeding five consecutive days.

Research evidence / Overview of studies for Lysozyme Hydrochloride

---

Evidence for Use in Acute Sore Throat and Pharyngeal Irritation

The available research includes short-term Randomized Controlled Trials (RCTs) and comparative pilot studies. Research explored how outcomes related to physical discomfort and difficulty swallowing change over defined time intervals in otherwise healthy adults.

Researchers described patterns observed in symptom scores over short periods, typically 2 to 7 days. Many reported outcomes were derived from studies of Lysozyme in combination with other active agents, rather than the enzyme preparation alone. The isolated effect of the single ingredient remains uncertain. Evidence is limited by short follow-up durations, meaning long-term effects are not fully established.

---

Evidence for Supportive Use in Oral Mucositis

Lysozyme Hydrochloride was evaluated as supportive care for oncology patients undergoing chemo- or radiotherapy. This evidence is derived from observational cohort studies and small pilot studies examining a specific comorbidity-defined group.

These studies measured outcomes linked to inflammatory states, such as the severity and density of ulceration and pain intensity. The certainty remains low for this indication. Limited information for long-term outcomes is available, and optimal dosage for supportive care in this setting is not fully established.

---

Evidence in Special Populations and Research Gaps

Research explored applications for general oral health, including biofilm formation and gingival status, mainly through small, preliminary pilot studies in young adults. This data often describes the enzyme as part of a multi-component regimen.

The results apply only to the populations studied. Data for certain groups remain insufficient, with limited information available for cohorts such as children or older adults. Overall, the evidence quality varies across studies, and research is ongoing to provide more comprehensive data, particularly for the single-active ingredient.

Key Studies & References

1. Lysozyme-based spray for treatment of radiotherapy-induced oral mucositis
2. Efficacy and safety of local lysozyme treatment in patients with oral mucositis after chemotherapy and radiotherapy

Common questions about Lysozyme Hydrochloride (FAQ)

---

Q: What is Lysozyme Hydrochloride used for?

According to official regulatory product information, Lysozyme Hydrochloride is used for the symptomatic treatment of certain inflammatory conditions affecting the mucous membranes of the mouth and throat. These conditions commonly include pharyngitis (sore throat) and stomatitis (inflammation of the mouth). The medicine is officially indicated for the relief of these associated localized symptoms.

---

Q: How does Lysozyme Hydrochloride work?

Regulatory information indicates that Lysozyme Hydrochloride functions as an enzyme that has both lytic and anti-inflammatory properties. Its lytic action helps break down bacterial cell walls, while its anti-inflammatory effects can help reduce localized swelling and pain. This combination is believed to contribute to the relief of symptoms in the affected areas.

---

Q: Does Lysozyme Hydrochloride kill bacteria?

Official product information suggests that Lysozyme Hydrochloride possesses a bacteriolytic action, meaning it can facilitate the breakdown of the cell walls of certain bacteria. This effect may help control the presence of some bacteria in the mouth and throat. However, the medicine's primary indication is for the local symptomatic relief of inflammation, leveraging its combined actions.

---

Q: Can Lysozyme Hydrochloride be used for children?

The official product label states that Lysozyme Hydrochloride is contraindicated (not to be used) in infants and children under the age of 2 years. For all individuals above this age, appropriate use is determined by the specific dosage form and the regulatory guidelines for children's medicine. Patients are encouraged to review the official patient information leaflet for complete age-specific directions.

---

Q: What should I do if I miss a dose?

Regulatory product information provides specific instructions for handling missed doses, detailing when to take a forgotten dose or when it should be skipped. Since dosing schedules vary, users should always refer to the medicine's official instructions for use for accurate, step-by-step guidance on how to proceed.

---

Q: Can I use Lysozyme Hydrochloride if I am pregnant or breastfeeding?

Regulatory documents acknowledge that insufficient data is available concerning the safety and effects of Lysozyme Hydrochloride during pregnancy and breastfeeding. The lack of definitive safety data means the use of this medicine requires professional medical judgment. A healthcare provider must assess the potential benefits against any possible risks before use.

---

Q: Can this medicine be used alongside antibiotics for a severe throat infection?

Official information does not typically list a specific reason (contraindication) not to use Lysozyme Hydrochloride while receiving concurrent systemic antibiotic therapy. The medicine is intended for local symptom relief. Evaluating the suitability of this medicine for use alongside other treatments, including antibiotics, typically involves a review by a healthcare provider.

How to Store and Dispose of Lysozyme Hydrochloride

Official regulatory information requires Lysozyme Hydrochloride to be stored in a cool, dry, and well-ventilated area. It is mandatory to protect the product from sunlight and keep the container tightly closed in its original packaging. Storage must keep the product away from heat and incompatible materials like strong oxidizers or alkalis.

Handling and Disposal

Handling requires avoiding the generation and breathing of dust. The product is stable under recommended conditions. Disposal of unused or expired Lysozyme Hydrochloride must be done through an authorized treatment and disposal facility in strict accordance with all applicable local and national regulations. The product must not be allowed to enter surface water or drains.